Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5614-5620
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5614
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5614
Figure 2 Stimulation of T cells by autologous DCs pulsed with hsp70-peptide complexes derived from SMMC-7721 cells.
DCs were incubated with 20 μg/mL hsp70-peptide complexes derived from SMMC- 7721 for 4 h at 37°C and cocultured with autologous T cells at different ratios for 5 d, and then tritiated thymidine was added and its incorporation was measured 18 h later. (A) 1 × 105 T cells were cocultured with 2 × 104 autologous DCs, pulsed with hsp70- peptide complexes (indicated as hsp70 stimulation) or unpulsed (indicated as DC control), or by themselves (indicated as T control) per well; (B) 1 × 105 autologous T cells were cocultured with 2 × 104, 1 × 104, or 3.3 × 103 DCs pulsed with hsp70-peptide complexes (indicated as hsp70 stimulation) or unpulsed (indicated as DC control) per well separately. The results are expressed as mean±SD and each value represents the mean of three replicates.
- Citation: Wang XH, Qin Y, Hu MH, Xie Y. Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses. World J Gastroenterol 2005; 11(36): 5614-5620
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5614.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5614